Coatue's Philippe Laffont Just Bought Shares of This Beaten-Down Growth Stock That Wall Street Predicts Will Soar 80%The Motley Fool • 03/04/25
Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV VaccineAccesswire • 02/28/25
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.The Motley Fool • 02/28/25
Moderna Tumbles As RFK Jr. Reportedly Mulls Pulling $590 Million In Bird Flu FundsInvestors Business Daily • 02/27/25
Moderna's stock stumbles on report HHS is reviewing a $590 million bird-flu-vaccine awardMarket Watch • 02/27/25
Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reportsReuters • 02/27/25
Vaccine Stocks Rise as Chinese Scientists Discover a New CoronavirusZacks Investment Research • 02/24/25
Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in ChinaInvestopedia • 02/21/25
Moderna shares move higher as investors look beyond Q4 losses to pipeline potentialProactive Investors • 02/18/25
Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release?Zacks Investment Research • 02/18/25
Moderna Q4 Earnings and Revenues Beat, COVID Vaccine Sales DeclineZacks Investment Research • 02/14/25